Add to ORKGParkinson's disease(PD) is characterized by a reduction of dopamine(DA) in the striatum and loss of dopaminergic neurons in the substantia nigra pars compacta.Recently,embryomc stem cells(ESCs) have been shown to be an effective source for cell replacement therapies for degenerating DA neurons.Howev...中国神经科学学会
Parkinson's disease (PD) patients display motor symptoms, e.g. tremor, rigidity and bradykinesia, la...
<div><p>Achieving safe and readily accessible sources for cell replacement therapy in Parkinson’s di...
Achieving safe and readily accessible sources for cell replacement therapy in Parkinson's disease (P...
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAM...
To test the in vivo effect of a high yield of dopaminergic (DA) neurons (90% of total neurons) which...
In Parkinson's disease (PD), the main pathology is a loss of nigrostriatal dopamine (DA) neurons. Cl...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective degeneration...
Embryonic stem (ES) cells have the ability to reproduce themselves for a long period and differentia...
Background: This study was performed to compare efficiency of embryonic stem (ES) cell-derived dopam...
In Parkinson's disease (PD), the main pathology underlying the motor symptoms is a loss of nigrostri...
Parkinson’s Disease (PD) is a neurodegenerative disorder where the dopamine producing neurons in the...
Parkinson's disease (PD) is the second most common neurodegenerative disease and affects 2% of the p...
Embryonic stem cell-based therapies exhibit great potential for the treatment of Parkinson's di...
Stimulation of endogenous repair in neurodegenerative diseases, such as Parkinson's disease (PD), ap...
Stimulation of endogenous repair in neurodegenerative diseases, such as Parkinson's disease (PD), ap...
Parkinson's disease (PD) patients display motor symptoms, e.g. tremor, rigidity and bradykinesia, la...
<div><p>Achieving safe and readily accessible sources for cell replacement therapy in Parkinson’s di...
Achieving safe and readily accessible sources for cell replacement therapy in Parkinson's disease (P...
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAM...
To test the in vivo effect of a high yield of dopaminergic (DA) neurons (90% of total neurons) which...
In Parkinson's disease (PD), the main pathology is a loss of nigrostriatal dopamine (DA) neurons. Cl...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective degeneration...
Embryonic stem (ES) cells have the ability to reproduce themselves for a long period and differentia...
Background: This study was performed to compare efficiency of embryonic stem (ES) cell-derived dopam...
In Parkinson's disease (PD), the main pathology underlying the motor symptoms is a loss of nigrostri...
Parkinson’s Disease (PD) is a neurodegenerative disorder where the dopamine producing neurons in the...
Parkinson's disease (PD) is the second most common neurodegenerative disease and affects 2% of the p...
Embryonic stem cell-based therapies exhibit great potential for the treatment of Parkinson's di...
Stimulation of endogenous repair in neurodegenerative diseases, such as Parkinson's disease (PD), ap...
Stimulation of endogenous repair in neurodegenerative diseases, such as Parkinson's disease (PD), ap...
Parkinson's disease (PD) patients display motor symptoms, e.g. tremor, rigidity and bradykinesia, la...
<div><p>Achieving safe and readily accessible sources for cell replacement therapy in Parkinson’s di...
Achieving safe and readily accessible sources for cell replacement therapy in Parkinson's disease (P...